HCAN:PA:PA-HSBC MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 24.085

Change

+0.06 (+0.25)%

Market Cap

USD 0.03B

Volume

293.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.19 (+0.42%)

USD 60.76B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.20 (-0.03%)

USD 13.44B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.03 (+0.01%)

USD 12.33B
WRD:PA HSBC MSCI World UCITS ETF

+0.02 (+0.04%)

USD 10.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-2.30 (-0.45%)

USD 8.88B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.20 (+0.49%)

USD 8.60B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.30 (+0.08%)

USD 7.71B
HHH:PA HSBC S&P 500 UCITS ETF

-0.02 (-0.03%)

USD 7.47B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.02 (+0.10%)

USD 6.81B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-0.36 (-0.22%)

USD 5.39B

ETFs Containing HCAN:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.54% 61% D- 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.54% 61% D- 60% D-
Trailing 12 Months  
Capital Gain 19.15% 65% D 74% C
Dividend Return 3.44% 71% C- 60% D-
Total Return 22.59% 72% C 78% C+
Trailing 5 Years  
Capital Gain 44.98% 65% D 74% C
Dividend Return 11.77% 51% F 45% F
Total Return 56.74% 71% C- 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 12.18% 68% D+ 69% C-
Dividend Return N/A 26% F 50% F
Total Return N/A 17% F 83% B
Risk Return Profile  
Volatility (Standard Deviation) N/A 65% D 50% F
Risk Adjusted Return N/A 31% F 50% F
Market Capitalization 0.03B 11% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.